Metraipolis › archive › dc_8bdc11ce2fdb
Immunoglobulin NGS enhance residual disease detection and prognosis in pediatric Ph+ acute lymphoblastic leukemia — Europe PMC PMID:41704536
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41704536
- DOI
- 10.3389/fimmu.2025.1677013
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T08:01:02.054Z
- SHA-256 of the archived text
fba407af7b1a1a2811ef6d62b3596f4166c734789f89ce46edb0a33799d0f650- Stable URL of this page
https://metraipolis.com/documento/dc_8bdc11ce2fdb
How to cite
Immunoglobulin NGS enhance residual disease detection and prognosis in pediatric Ph+ acute lymphoblastic leukemia — Europe PMC PMID:41704536 — Europe PMC (en), https://europepmc.org/article/MED/41704536 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8bdc11ce2fdb (Metraipolis archive dc_8bdc11ce2fdb, sha256 fba407af7b1a1a2811ef6d62b3596f4166c734789f89ce46edb0a33799d0f650)
BibTeX
@misc{dc8bdc11ce2fdb,
title = {Immunoglobulin NGS enhance residual disease detection and prognosis in pediatric Ph+ acute lymphoblastic leukemia — Europe PMC PMID:41704536},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41704536},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8bdc11ce2fdb; sha256 fba407af7b1a1a2811ef6d62b3596f4166c734789f89ce46edb0a33799d0f650},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41704536. Agents can read the archived copy with the MCP tool read_document.